LEADERSHIP.
EMPOWERMENT.
DEVELOPMENT.

Target Audience

This activity has been designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and the other health professionals interested in the treatment and diagnosis of lymphoma.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Compare and contrast the latest approaches to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma
  • Evaluate current and emerging approaches to the treatment of patients with Hodgkin lymphoma
  • Assess the latest clinical trial data of current and emerging CAR T-cells and cellular therapy for patients with hematologic malignancies, including important safety and efficacy data
  • Discuss patient and disease-related factors that impact the selection and sequencing of therapy for patients with CLL
  • Develop strategies to utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma